Company Encyclopedia
View More
name
Inspire Medical
INSP.US
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
1.407 T
INSP.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking21/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.54%C
    • Profit Margin5.05%C
    • Gross Margin85.85%A
  • Growth ScoreB
    • Revenue YoY16.81%B
    • Net Profit YoY34.82%B
    • Total Assets YoY1.45%C
    • Net Assets YoY-4.32%D
  • Cash ScoreB
    • Cash Flow Margin1980.93%A
    • OCF YoY16.81%B
  • Operating ScoreA
    • Turnover1.1A
  • Debt ScoreA
    • Gearing Ratio17.49%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Dir McCormick Sells 1,200 ($166.8K) Of Inspire Medical Systems Inc [INSP]

    Director Shawn McCormick of Inspire Medical Systems Inc filed a Form 4 with the SEC, disclosing a planned sale of 1,200 shares at $139 each, totaling $166,800, under a prearranged trading plan (10b5-1). His ending holdings are 27,846 shares. The Washington Service offers insider trading analysis and data services.

    Reuters·
    US
    INSP
    +3.92%
    Reuters·
    US
    INSP
    +3.92%

    Inspire Medical Systems Director Shawn McCormick Reports Sale of Common Shares

    Shawn McCormick, Director at Inspire Medical Systems Inc., reported the sale of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This news brief was created by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    INSP
    +3.92%
    Reuters·
    US
    INSP
    +3.92%

    Inspire Medical Systems Faces Investor Lawsuit Over Inspire V Launch

    Inspire Medical Systems Inc. faces a class action lawsuit from investors over losses linked to the Inspire V launch. The lawsuit claims the company made false statements and concealed issues such as poor demand, inadequate training, and IT setup failures, contradicting public assurances of a successful launch. These alleged failures led to investor losses between August 2024 and August 2025.

    Reuters·
    US
    INSP
    +3.92%
    Reuters·
    US
    INSP
    +3.92%

    14:52 ET Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5

    Inspire Medical Systems (INSP) faces a securities class action lawsuit due to alleged misrepresentation of operational readiness for the Inspire V launch, leading to a 32% stock crash and 80% EPS guidance cut. Hagens Berman urges affected investors to contact them by Jan. 5, 2026, for lead plaintiff appointment. The lawsuit scrutinizes billing code errors and inventory issues that were allegedly concealed, impacting stock prices.

    prnewswire·
    US
    INSP
    +3.92%
    prnewswire·
    US
    INSP
    +3.92%

    Insider Selling: Inspire Medical Systems (NYSE:INSP) Director Sells 2,000 Shares of Stock

    Inspire Medical Systems Director Shawn McCormick sold 2,000 shares, reducing his stake by 7.13%. The company beat quarterly expectations with EPS of $0.38 and revenue of $224.5M, and announced a $200M share buyback plan. Analyst sentiment is mixed, with a "Moderate Buy" consensus and a $134.88 target. INSP has a market cap of $3.69B and a 52-week range of $70.77–$216.01.

    Market Beat·
    US
    INSP
    +3.92%
    Market Beat·
    US
    INSP
    +3.92%
    © 2025 Longbridge｜Disclaimer